Cui; Bing

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cui; Bing.The latest application filed is for "therapeutic antibodies against ror-1 protein and methods for use of same".

Company Profile

4.12.12

Cui; Bing - San Diego CA
Cui; Bing - Beijing N/A CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis Grant 11,312,787 - Kipps , et al. April 26, 2	2022-04-26
Dry connection prefabricated assembly steel-concrete composite beam Grant 11,105,084 - Cui , et al. August 31, 2	2021-08-31
Therapeutic Antibodies Against Ror-1 Protein And Methods For Use Of Same App 20210208158 - Kipps; Thomas J. ; et al.	2021-07-08
Cancer Treatment Combinations App 20210038716 - Kipps; Thomas J. ; et al.	2021-02-11
Therapeutic antibodies against ROR-1 protein and methods for use of same Grant 10,900,973 - Kipps , et al. January 26, 2	2021-01-26
Therapeutic Antibodies Against Ror-1 Protein And Methods For Use Of Same App 20200309785 - Kipps; Thomas J. ; et al.	2020-10-01
Cancer treatment combinations Grant 10,688,181 - Kipps , et al.	2020-06-23
Therapeutic antibodies against ROR-1 protein and methods for use of same Grant 10,627,409 - Kipps , et al.	2020-04-21
Antibodies And Vaccines For Use In Treating Ror1 Cancers And Inhibiting Metastasis App 20190389962 - Kipps; Thomas James ; et al.	2019-12-26
Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis Grant 10,344,096 - Kipps , et al. July 9, 2	2019-07-09
Therapeutic Antibodies Against Ror-1 Protein And Methods For Use Of Same App 20180348232 - Kipps; Thomas J. ; et al.	2018-12-06
Therapeutic antibodies against ROR-1 protein and methods for use of same Grant 9,933,434 - Kipps , et al. April 3, 2	2018-04-03
Antibodies And Vaccines For Use In Treating Ror1 Cancers And Inhibiting Metastasis App 20180066063 - Kipps; Thomas James ; et al.	2018-03-08
Cancer Treatment Combinations App 20170368173 - Kipps; Thomas J. ; et al.	2017-12-28
Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis Grant 9,758,591 - Kipps , et al. September 12, 2	2017-09-12
Therapeutic Antibodies Against Ror-1 Protein And Methods For Use Of Same App 20170248585 - Kipps; Thomas J. ; et al.	2017-08-31
Therapeutic antibodies against ROR-1 protein and methods for use of same Grant 9,523,695 - Kipps , et al. December 20, 2	2016-12-20
Therapeutic Antibodies Against Ror-1 Protein And Methods For Use Of Same App 20160097776 - Kipps; Thomas J. ; et al.	2016-04-07
Therapeutic antibodies against ROR-1 protein and methods for use of same Grant 9,217,040 - Kipps , et al. December 22, 2	2015-12-22
Antibodies And Vaccines For Use In Treating Ror1 Cancers And Inhibiting Metastasis App 20150232569 - Kipps; Thomas James ; et al.	2015-08-20
Therapeutic Antibodies against ROR-1 Protein and Methods for Use of Same App 20130273073 - Kipps; Thomas J. ; et al.	2013-10-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.